MetaADEDB 2.0 @ LMMD
Fluocinolone Acetonide
(FEBLZLNTKCEFIT-VSXGLTOVSA-N)
Structure
SMILES
OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@]2([C@H]1C[C@@H](C1=CC(=O)C=C[C@]21C)F)F)(C)C
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
C05AA10; D07AC04; D07BC02; D07CC02; S01BA15; S01CA10; S02BA08; S02CA05
Molecular Formula:
C24H30F2O6
Molecular Weight:
452.488
Log P:
2.3668
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
93.06
CAS Number(s):
67-73-2
Synonym(s)
1.
Fluocinolone Acetonide
2.
Fluortriamcinolone Acetonide
3.
Alvadermo
4.
Capex
5.
Co-Fluocin
6.
Cortiespec
7.
Derma-Smooth FS
8.
Flucinar
9.
Fluocid
10.
Fluodermo
11.
Fluonid
12.
Fluotrex
13.
Flurosyn
14.
Flusolgen
15.
Gelidina
16.
Jellin
17.
Jellisoft
18.
Synalar
19.
Synalar-HP
20.
Synamol
21.
Synemol
22.
Acetonide, Fluocinolone
23.
Acetonide, Fluortriamcinolone
24.
Co Fluocin
25.
Derma Smooth FS
26.
Synalar HP
External Link(s)
MeSHD005446
PubChem Compound6215
ChEBI31623
CHEMBLCHEMBL989
DrugBankDB00591
DrugCentral1204
IUPHAR/BPS Guide to PHARMACOLOGY7077
KEGGdr:D01825
Therapeutic Target DatabaseD02QJH
ZINC3977981
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Device dislocationFAERS: 11US FAERS
2Drug ineffectiveFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
3BlindnessFAERS: 9US FAERS
4Medical device removalFAERS: 9US FAERS
5VitrectomyFAERS: 9OFFSIDES
US FAERS
6Eye painFAERS: 6US FAERS
7EndophthalmitisFAERS: 5OFFSIDES
US FAERS
8ErythemaFAERS: 5US FAERS
9Vitreous floatersFAERS: 5US FAERS
10AlopeciaFAERS: 4US FAERS
11CataractFAERS: 415767049
24999722
CTD
OFFSIDES
US FAERS
12Device breakageFAERS: 4OFFSIDES
US FAERS
13Eye irritationFAERS: 4US FAERS
14Post procedural complicationFAERS: 4US FAERS
15Product quality issueFAERS: 4OFFSIDES
US FAERS
16Product substitution issueFAERS: 4US FAERS
17PruritusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
18UrticariaFAERS: 4US FAERS
19Visual ImpairmentFAERS: 4US FAERS
20Application site painFAERS: 3US FAERS
21Application site pruritusFAERS: 3US FAERS
22Burning sensationFAERS: 3OFFSIDES
US FAERS
23Expired product administeredFAERS: 3US FAERS
24Eye laser surgeryFAERS: 3US FAERS
25GlaucomaFAERS: 3OFFSIDES
US FAERS
26HeadacheFAERS: 3US FAERS
27Macular fibrosisFAERS: 3US FAERS
28Retinal DetachmentFAERS: 3US FAERS
29Accidental exposure to productFAERS: 2US FAERS
30Accidental exposureFAERS: 2US FAERS
31Angle Closure GlaucomaFAERS: 2US FAERS
32AphakiaFAERS: 2OFFSIDES
US FAERS
33Corneal ScarFAERS: 2US FAERS
34Descemet's membrane disorderFAERS: 2US FAERS
35Device FailureFAERS: 2US FAERS
36Disease recurrenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
37DyschromatopsiaFAERS: 2US FAERS
38Glaucoma drainage device placementFAERS: 2US FAERS
39HypersensitivityFAERS: 2US FAERS
40Implant site extravasationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
41InflammationFAERS: 224999722CTD
US FAERS
42Intentional product use issueFAERS: 2US FAERS
43MetamorphopsiaFAERS: 2US FAERS
44Retinal DegenerationFAERS: 2US FAERS
45Retinal pigment epithelial tearFAERS: 2US FAERS
46RetinoschisisFAERS: 2OFFSIDES
US FAERS
47ScabFAERS: 2OFFSIDES
US FAERS
48Therapy non-responderFAERS: 2US FAERS
49UveitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
50AcneFAERS: 1OFFSIDES
US FAERS
51Activities of daily living impairedFAERS: 1US FAERS
52Administration site inflammationFAERS: 1US FAERS
53Anterior chamber flareFAERS: 1US FAERS
54AnxietyFAERS: 1US FAERS
55Application site irritationFAERS: 1US FAERS
56Blood glucose increasedFAERS: 1US FAERS
57Chemical injuryFAERS: 1US FAERS
58ChillsFAERS: 1US FAERS
59Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
60Corneal Endothelial Cell LossFAERS: 1US FAERS
61Culture positiveFAERS: 1US FAERS
62Cytomegalovirus chorioretinitisFAERS: 1US FAERS
63DeafnessFAERS: 1US FAERS
64DermatitisFAERS: 1US FAERS
65Device expulsionFAERS: 1US FAERS
66Device extrusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Device material opacificationFAERS: 1US FAERS
68Drug dispensing errorFAERS: 1US FAERS
69Drug ineffective for unapproved indicationFAERS: 1US FAERS
70Drug prescribing errorFAERS: 1US FAERS
71Dry skinFAERS: 1US FAERS
72Ear discomfortFAERS: 1US FAERS
73Economic problemFAERS: 1US FAERS
74EczemaFAERS: 1OFFSIDES
US FAERS
75Eye complication associated with deviceFAERS: 1US FAERS
76Eye inflammationFAERS: 1US FAERS
77FatigueFAERS: 1OFFSIDES
US FAERS
78Feeling jitteryFAERS: 1US FAERS
79Genital rashFAERS: 1US FAERS
80Impaired driving abilityFAERS: 1US FAERS
81Implant site reactionFAERS: 1US FAERS
82Incorrect dose administeredFAERS: 1US FAERS
83Incorrect route of drug administrationFAERS: 1US FAERS
84Internal limiting membrane peelingFAERS: 1US FAERS
85Intraocular lens dislocationFAERS: 1US FAERS
86Intraocular pressure test abnormalFAERS: 1US FAERS
87IridocyclitisFAERS: 1US FAERS
88KeratoconusFAERS: 1US FAERS
89KeratopathyFAERS: 1US FAERS
90LethargyFAERS: 1US FAERS
91Medical device complicationFAERS: 1US FAERS
92Medication ErrorFAERS: 1US FAERS
93Migration of implanted drugFAERS: 1US FAERS
94NasopharyngitisFAERS: 1US FAERS
95NauseaFAERS: 1US FAERS
96NervousnessFAERS: 1US FAERS
97No adverse eventFAERS: 1US FAERS
98Ocular HypertensionFAERS: 1

View details

CTD
US FAERS
99Ocular vasculitisFAERS: 1US FAERS
100PainFAERS: 1OFFSIDES
US FAERS
101Product container issueFAERS: 1US FAERS
102Product packaging confusionFAERS: 1US FAERS
103Product sterility lackingFAERS: 1US FAERS
104Product use issueFAERS: 1US FAERS
105PsoriasisFAERS: 1OFFSIDES
US FAERS
106Rash erythematousFAERS: 1US FAERS
107Scleral thinningFAERS: 1US FAERS
108ScleritisFAERS: 1US FAERS
109Skin irritationFAERS: 1US FAERS
110Subretinal fibrosisFAERS: 1US FAERS
111Suture related complicationFAERS: 1OFFSIDES
US FAERS
112SwellingFAERS: 1US FAERS
113Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
114Toxicity to various agentsFAERS: 1US FAERS
115UlcerFAERS: 1US FAERS
116Unevaluable eventFAERS: 1US FAERS
117Vitreous fibrinFAERS: 1US FAERS
118VitritisFAERS: 1US FAERS
119VomitingFAERS: 1US FAERS
120Weight decreasedFAERS: 1US FAERS
121Abdominal PainOFFSIDES
122Abdominal discomfortOFFSIDES
123AbuseOFFSIDES
124Acid refluxOFFSIDES
125Alcohol abuseOFFSIDES
126Anal FissureOFFSIDES
127Angioid Streaks15767049CTD
128Anorectal discomfortOFFSIDES
129Application site reactionCanada Vigilance: 1Canada Vigilance
130ArteriosclerosisOFFSIDES
131AstheniaOFFSIDES
132AsthmaOFFSIDES
133AtelectasisOFFSIDES
134Basal cell carcinomaOFFSIDES
135Bipolar II disorderOFFSIDES
136Birdshot Chorioretinopathy24999722CTD
137Blood GlucoseOFFSIDES
138Blood alkaline phosphatase increasedOFFSIDES
139Blood cholesterolOFFSIDES
140Blood potassium increasedOFFSIDES
141Blood triglycerides increasedOFFSIDES
142Blood urine presentOFFSIDES
143Bone density decreasedOFFSIDES
144Bone lesionOFFSIDES
145Borderline Personality DisorderOFFSIDES
146BronchitisOFFSIDES
147BursitisOFFSIDES
148CellulitisOFFSIDES
149Choroidal Neovascularization15767049CTD
150Conjunctival primary acquired melanosisOFFSIDES
151Corneal decompensationOFFSIDES
152DiabetesOFFSIDES
153DiarrheaOFFSIDES
154Drug Eruptions4278287CTD
155Drug withdrawal headacheOFFSIDES
156Emotional distressOFFSIDES
157EndometriosisOFFSIDES
158Essential HypertensionOFFSIDES
159Facial NeuralgiaOFFSIDES
160Factor V Leiden mutationOFFSIDES
161Foaming at mouthOFFSIDES
162GastroenteritisOFFSIDES
163Genital HerpesOFFSIDES
164HepatosplenomegalyOFFSIDES
165HerniaOFFSIDES
166Histoplasmosis15767049CTD
167HypophagiaOFFSIDES
168InfectionOFFSIDES
169Infectious MononucleosisOFFSIDES
170Joint Range of Motion DecreasedOFFSIDES
171Joint injuryOFFSIDES
172Joint sprainOFFSIDES
173Joint stiffnessOFFSIDES
174Left Ventricular HypertrophyOFFSIDES
175Life expectancy shortenedOFFSIDES
176Lupus-like syndromeOFFSIDES
177Lymphocytic infiltrationOFFSIDES
178Malignant melanoma stage IOFFSIDES
179Multiple allergiesOFFSIDES
180Muscle WeaknessOFFSIDES
181Musculoskeletal discomfortOFFSIDES
182Mycosis FungoidesOFFSIDES
183NeuralgiaOFFSIDES
184Nodular regenerative hyperplasiaOFFSIDES
185Optic AtrophyOFFSIDES
186Optic NeuropathyOFFSIDES
187Oropharyngeal painOFFSIDES
188OsteopeniaOFFSIDES
189OsteosclerosisOFFSIDES
190OverdoseOFFSIDES
191Perirectal abscessOFFSIDES
192PneumothoraxOFFSIDES
193Productive CoughOFFSIDES
194Pulmonary HypertensionOFFSIDES
195Purulent dischargeOFFSIDES
196Respiratory tract congestionOFFSIDES
197Retinal Vein Occlusion15767049CTD
198RhinorrheaOFFSIDES
199Schizoaffective DisorderOFFSIDES
200Sinus bradycardiaOFFSIDES
201SinusitisOFFSIDES
202Skin lacerationOFFSIDES
203Skin lesionOFFSIDES
204Skin neoplasm excisionOFFSIDES
205Stevens-Johnson SyndromeOFFSIDES
206StressOFFSIDES
207Tardive DyskinesiaOFFSIDES
208Telangiectasis952530CTD
209Tooth ExtractionOFFSIDES
210Tooth InfectionOFFSIDES
211TracheitisOFFSIDES
212Venous InsufficiencyOFFSIDES
213VertebroplastyOFFSIDES
214Walking aid userOFFSIDES
215Weight GainOFFSIDES
216Wound InfectionOFFSIDES
217Wound infection staphylococcalOFFSIDES
218colonoscopyOFFSIDES
219effusionOFFSIDES
220furuncleOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.